1. bklein64
2. srktlk
3. rmekevincannon
4. anthonyr394
5. plex76
1.azweiso6 02/26/2018
Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorization in Europe for the Treatment of X-Linked Hypophosphatemia in Children
2.srktlk 01/24/2018
3.bklein64 01/08/2018
News - Ultragenyx Announces Positive Interim Topline Results From First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency
4.cafereyes 01/29/2018
Ultragenyx Appoints Camille L. Bedrosian, M.D. as Chief Medical Officer and Executive Vice President
5.anthonyr394 01/24/2018
You dont see stocks go up often after an offering, I like it!
6.bklein64 02/21/2018
Stifel Nicolaus cuts price target to $74 from $85
7.srktlk 02/21/2018
Morgan Stanley raises PT to $60 from $57
8.bklein64 02/21/2018
Ultragenyx Reports Fourth Quarter and Full Year 2017 Financial Results and Corporate Update
9.azweiso6 05/07/2018
Beats EPS estimates by $0.81. Misses on revenues.
10.bklein64 01/24/2018
Ultragenyx Announces Proposed Public Offering of Common Stock
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW